Biohaven Pharmaceutical Holding Co (BHVN)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from BHVN's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Biohaven Pharmaceutical Holding Co's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | -$214M | -$570M | -$408M | -$846M | -$739M |
| Free cash flow | -$147M | -$304M | -$335M | -$587M | -$610M |
| EPS (diluted) | -$5.43 | -$12.75 | -$5.73 | -$9.28 | -$6.86 |
| Operating margin | — | — | — | — | — |
Superinvestors who own BHVN
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $62M | 0.02% | Q2 2026 |
Insider buying
Open-market purchases by Biohaven Pharmaceutical Holding Co's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 17, 2025 | George C Clark |
17,000 | $8.52 | $144,840 |
| Nov 13, 2025 | Gregory Bailey |
400,000 | $7.50 | $3M |
| Nov 13, 2025 | John W Childs |
3,333,333 | $7.50 | $25M |
| Nov 13, 2025 | Vlad Coric |
666,666 | $7.50 | $5M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when BHVN trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Biohaven Pharmaceutical Holding Co insiders buying the stock?
4 open-market insider purchases of BHVN in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Biohaven Pharmaceutical Holding Co?
1 of the superinvestors Investingly tracks hold BHVN in their latest 13F, including Cliff Asness.
Companies like Biohaven Pharmaceutical Holding Co
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.